Neurofibromatosis Type 1: Modeling CNS Dysfunction

被引:60
|
作者
Gutmann, David H. [1 ]
Parada, Luis F. [2 ]
Silva, Alcino J. [3 ]
Ratner, Nancy [4 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源
JOURNAL OF NEUROSCIENCE | 2012年 / 32卷 / 41期
基金
美国国家卫生研究院;
关键词
CORPUS-CALLOSUM MORPHOLOGY; MOUSE MODEL; PROGENITOR PROLIFERATION; GLIOMA FORMATION; ABERRANT GROWTH; NF1; GENE; BRAIN; CHILDREN; PATHWAY; DIFFERENTIATION;
D O I
10.1523/JNEUROSCI.3242-12.2012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial neoplasms (optic gliomas, malignant astrocytomas) and neuronal dysfunction (learning disabilities, attention deficits). Nf1 genetically engineered mouse models have revealed the molecular and cellular underpinnings of gliomagenesis, attention deficit, and learning problems with relevance to basic neurobiology. Using NF1 as a model system, these studies have revealed critical roles for the NF1 gene in non-neoplastic cells in the tumor microenvironment, the importance of brain region heterogeneity, novel mechanisms of glial growth regulation, the neurochemical bases for attention deficit and learning abnormalities, and new insights into neural stem cell function. Here we review recent studies, presented at a symposium at the 2012 Society for Neuroscience annual meeting, that highlight unexpected cell biology insights into RAS and cAMP pathway effects on neural progenitor signaling, neuronal function, and oligodendrocyte lineage differentiation.
引用
收藏
页码:14087 / 14093
页数:7
相关论文
共 50 条
  • [41] CNS Tumors in Neurofibromatosis
    Campian, Jian
    Gutmann, David H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (21) : 2378 - +
  • [42] CNS FINDINGS IN NEUROFIBROMATOSIS
    BERGMANN, M
    KUCHELMEISTER, K
    HEIDL, G
    GULLOTTA, F
    ACTA HISTOCHEMICA, 1992, : 215 - 219
  • [43] neurofibromatosis type-1 independent variants in a neurofibromatosis type-1 family
    Metaxa, Rafaella
    Miltiadous, Andri
    Gerasimou, Petroula
    Petridou, Natasa
    Athanasiou, Emily
    Costeas, Paul
    Anastasiadou, Violetta
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1221 - 1221
  • [44] A Review of Spinal Lesions in Neurofibromatosis Type 1 in a Large Neurofibromatosis Type 1 Center
    Sial, Moska
    George, K. Joshi
    WORLD NEUROSURGERY, 2023, 169 : E157 - E163
  • [45] Molecular mechanisms of cognitive dysfunction in neurofibromatosis type I
    Costa, RM
    Elgersma, Y
    Yang, T
    Kogan, JH
    Haynh, DP
    Brannan, CI
    Silva, AJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 201 - 201
  • [46] Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1
    Santoro, Claudia
    Picariello, Stefania
    Palladino, Federica
    Spennato, Pietro
    Melis, Daniela
    Roth, Jonathan
    Cirillo, Mario
    Quaglietta, Lucia
    D'Amico, Alessandra
    Gaudino, Giuseppina
    Meucci, Maria Chiara
    Ferrara, Ursula
    Constantini, Shlomi
    Perrotta, Silverio
    Cinalli, Giuseppe
    CANCERS, 2020, 12 (06)
  • [47] Neurofibromatosis type 1 and high-grade tumors of the CNS: The children's memorial hospital experience
    Rosenfeld, Amy
    Listernick, Robert
    Charrow, Joel
    Goldman, Stewart
    NEURO-ONCOLOGY, 2008, 10 (03) : 463 - 463
  • [48] MARKED MESENTERIAL NEUROFIBROMATOSIS IN TYPE-1 NEUROFIBROMATOSIS
    GOTZINGER, RP
    BITTINGER, A
    NIES, C
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1994, 160 (03): : 277 - 279
  • [49] Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1
    Reynolds, RM
    Browning, GGP
    Nawroz, I
    Campbell, IW
    LANCET, 2003, 361 (9368): : 1552 - 1554
  • [50] Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1)
    Guillamo, JS
    Créange, A
    Kalifa, C
    Grill, J
    Rodriguez, D
    Doz, F
    Barbarot, S
    Zerah, M
    Sanson, M
    Bastuji-Garin, S
    Wolkenstein, P
    BRAIN, 2003, 126 : 152 - 160